Literature DB >> 18824096

Intraorally fast-dissolving particles of a poorly soluble drug: preparation and in vitro characterization.

Riikka Laitinen1, Eero Suihko, Kaisa Toukola, Mikko Björkqvist, Joakim Riikonen, Vesa Pekka Lehto, Kristiina Järvinen, Jarkko Ketolainen.   

Abstract

In this study, the dissolution rate of a poorly soluble drug, perphenazine (PPZ) was improved by a solid dispersion technique to permit its usage in intraoral formulations. Dissolution of PPZ (4 mg) in a small liquid volume (3 ml, pH 6.8) within one minute was set as the objective. PVP K30 and PEG 8000 were selected for carriers according to the solubility parameter approach and their 5/1, 1/5 and 1/20 mixtures with PPZ (PPZ/polymer w/w) were prepared by freeze-drying from 0.1 N HCl solutions. The dissolution rate of PPZ was improved with all drug/polymer mixture ratios compared to crystalline or micronized PPZ. A major dissolution rate improvement was seen with 1/5 PPZ/PEG formulation, i.e. PPZ was dissolved completely within one minute. SAXS, DSC and XRPD measurements indicated that solid solutions of amorphous PPZ in amorphous PVP or in partly amorphous PEG were formed. DSC and FTIR studies suggested that PPZ dihydrochloride salt was formed and hydrogen bonding was occurred between PPZ and the polymers. It was concluded that molecular mixing together with salt formation promoted the dissolution of PPZ, especially in the case of the 1/5 PPZ/PEG dispersion, making it a promising candidate for use in intraoral formulations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18824096     DOI: 10.1016/j.ejpb.2008.09.001

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  1 in total

1.  Mechanistic insights into acyclovir-polyethylene glycol 20000 binary dispersions.

Authors:  Krishnamoorthy Venkateskumar; Subramani Parasuraman; Raju Gunasunderi; Krishnan Sureshkumar; M Muralidhar Nayak; Syed Adnan Ali Shah; Khoo Kassen; Heng Wei Kai
Journal:  Int J Pharm Investig       Date:  2016 Oct-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.